A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters
Abstract
Purpose The aim of this study was to collect and describe all published reports of local tissue injury or extravasation from vasopressor administration via either peripheral intravenous (IV) or central venous catheter.Methods A systematic search of Medline, Embase, and Cochrane databases was performed from inception through January 2014 for reports of adults who received vasopressor intravenously via peripheral IV or central venous catheter for a therapeutic purpose. We included primary studies or case reports of vasopressor administration that resulted in local tissue injury or extravasation of vasopressor solution.Results Eighty-five articles with 270 patients met all inclusion criteria. A total of 325 separate local tissue injury and extravasation events were identified, with 318 events resulting from peripheral vasopressor administration and 7 events resulting from central administration. There were 204 local tissue injury events from peripheral administration of vasopressors, with an average duration of infusion of 55.9 hours (±68.1), median time of 24 hours, and range of 0.08 to 528 hours. In most of these events (174/204, 85.3%), the infusion site was located distal to the antecubital or popliteal fossae.Conclusions Published data on tissue injury or extravasation from vasopressor administration via peripheral IVs are derived mainly from case reports. Further study is warranted to clarify the safety of vasopressor administration via peripheral IVs.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
We identified direct evidence from 14 RCTs (n = 4,499 patients) that assessed use of procalcitonin to guide antimicrobial treatment duration in patients with sepsis.
“We identified direct evidence from 14 RCTs (n = 4,499 patients) that assessed use of procalcitonin to guide antimicrobial treatment duration in patients with sepsis (two trials included critically ill patients in general) (308-321).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [312]
Local tissue injury may be more likely with prolonged administration of vasopressors.
“The occurrence of local tissue injury may be more likely with prolonged administration of vasopressors.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [389]
Administration of vasopressors for less than 6 hours in a well-placed peripheral catheter proximal to the antecubital fossa is unlikely to cause local tissue injury.
“Administration of vasopressors for a short period of time (< 6 h) in a well-placed peripheral catheter proximal to the antecubital fossa is unlikely to cause local tissue injury [389].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [389]
Extravasation may occur more frequently if vasopressors are infused distal to the antecubital fossa; a meta-analysis found 85% of reported extravasation events occurred with a catheter distal to the antecubital fossa.
“Extravasation may occur more frequently if vasopressors are infused distally to the antecubital fossa; a meta-analysis showed that 85% of reported extravasation events occurred when vasopressors were infused by a catheter that was located distal to the antecubital fossa [389].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [389]
Most studies reported no need for active treatment of extravasation, and a systematic review concluded most patients with extravasation have no long-term sequelae.
“Most of the studies reported no need for active treatment of the extravasation, and a systematic review concluded that most patients who experience extravasation events have no long-term sequelae [389].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [389]
Cites
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694 · see citing works
Martin, R. (1986) · Medical Entomology and Zoology · Cited by 8,743 · see citing works
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,282 · see citing works
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924 · see citing works
Rosen's emergency medicine : concepts and clinical practice.
Marx, J. A. (2017) · Cited by 1,262 · see citing works
Rosenʼs emergency medicine: concepts and clinical practice
Rotheray, K. R., & Cattermole, G. N. (2010) · European Journal of Emergency Medicine · doi:10.1097/mej.0b013e32833728f4 · Cited by 1,128 · see citing works
Central venous catheterization
Taylor, R. W., & Palagiri, A. V. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000260241.80346.1b · Cited by 302 · see citing works
Ansford, A. J., Findlay, A., & Brushe, J. M. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92941-4 · Cited by 288 · see citing works
Ebels, T., & van der Heide, J. N. H. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90264-1 · Cited by 188 · see citing works
Major intravenous extravasation injuries
Upton, J. M., Mulliken, J. B., & Murray, J. E. (1979) · The American Journal of Surgery · doi:10.1016/0002-9610(79)90121-1 · Cited by 158 · see citing works
Ricard, J.-D., Salomon, L., Boyer, A., Thiery, G., Meybeck, A., Roy, C., Pasquet, B., Le Mière, E., & Dreyfuss, D. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828a42c5 · Cited by 104 · see citing works
Skin necrosis after extravasation of low-dose vasopressin administered for septic shock
Kahn, J. M., Kress, J. P., & Hall, J. B. (2002) · Critical Care Medicine · doi:10.1097/00003246-200208000-00038 · Cited by 85 · see citing works
Kurland, G. S., & Malach, M. (1952) · New England Journal of Medicine · doi:10.1056/nejm195209112471102 · Cited by 79 · see citing works
TISSUE NECROSIS CAUSED BY COMMONLY USED INTRAVENOUS INFUSIONS
Gaze, N. R. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91879-2 · Cited by 67 · see citing works
Putland, M., Kerr, D. C., & Kelly, A. (2006) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.01.022 · Cited by 52 · see citing works
USE OF PHENTOLAMINE TO PREVENT NECROSIS DUE TO LEVARTERENOL
Zucker, G. (1957) · JAMA · doi:10.1001/jama.1957.82970510001009 · Cited by 48 · see citing works
Skin Necrosis Following Intravenous Noradrenaline
Humphreys, J., Johnston, J. H., & Richardson, J. C. (1955) · BMJ · doi:10.1136/bmj.2.4950.1250 · Cited by 47 · see citing works
Tissue Necrosis Following Subcutaneous Infiltration with Nor-Epinephrine
Greenwald, H. P., Gootnick, A., Luger, N. M., & King, J. A. (1952) · New England Journal of Medicine · doi:10.1056/nejm195202142460704 · Cited by 44 · see citing works
Extravasation Injury Associated with Low-Dose Dopamine
Chen, J. L., & O'Shea, M. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17184 · Cited by 43 · see citing works
Use of subcutaneous terbutaline to reverse peripheral ischemia
Stier, P. A., Bogner, M. P., Webster, K., et al. (1999) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(99)90028-1 · Cited by 40 · see citing works
Local gangrene: A complication of peripheral pitressin therapy for bleeding esophageal varices
Greenwald, R. A., Rheingold, O. J., Chiprut, R. O., et al. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90255-x · Cited by 33 · see citing works
Management and Prevention of Infiltration and Extravasation Injury
Lynch, D. J., White, R. R., & Key, J. C. (1979) · Surgical Clinics of North America · doi:10.1016/s0039-6109(16)41940-7 · Cited by 28 · see citing works
Skin necrosis following intravenous use of norepinephrine
Shapiro, R. A., & Perlon, S. (1956) · The American Journal of Surgery · doi:10.1016/s0002-9610(56)80088-3 · Cited by 27 · see citing works
ULCERATION OF THE SKIN FOLLOWING INTRAVENOUS USE OF ARTERENOL
Uricchio, J. F. (1953) · JAMA · doi:10.1001/jama.1953.63690070003010b · Cited by 27 · see citing works
Avoidance of vascular complications associated with the use of dopamine
Stetson, J. B., & Reading, G. (1977) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03006717 · Cited by 26 · see citing works
Gangrene Resulting from Infiltrated Dopamine Solution
Boltax, R. S., Dineen, J. P., & Scarpa, F. J. (1977) · New England Journal of Medicine · doi:10.1056/nejm197704072961426 · Cited by 26 · see citing works
Development of cutaneous gangrene during continuous peripheral infusion of vasopressin.
Anderson, J. R., & Johnston, G. W. (1983) · BMJ · doi:10.1136/bmj.287.6406.1657 · Cited by 23 · see citing works
Infected gangrene. A serious complication of peripheral vasopressin administration.
Mogan, G. R., Wormser, G. P., & Gottfried, E. B. (1980) · PubMed · Cited by 23 · see citing works
Peripheral dopamine infusions: are they worth the risk of infiltration?
Dugger, B. (1997) · PubMed · Cited by 21 · see citing works
Tissue necrosis due to norepinephrine
Oglesby, J. E., & Baugh, J. H. (1968) · The American Journal of Surgery · doi:10.1016/0002-9610(68)90171-2 · Cited by 21 · see citing works
Well recognised but still overlooked: norepinephrine extravasation: Figure 1
Kim, S. M., Aikat, S., & Bailey, A. L. (2012) · BMJ Case Reports · doi:10.1136/bcr-2012-006836 · Cited by 19 · see citing works
[A case of peripheral ischemic complication after terlipressin therapy].
Lee, J. S., Lee, H. S., Jung, S. W., et al. (2006) · PubMed · Cited by 19 · see citing works
Skin sloughs associated with levophed
McGinn, J. T., & Schluger, J. (1956) · The American Journal of Surgery · doi:10.1016/s0002-9610(56)80091-3 · Cited by 18 · see citing works
Tran, D. Q. H., & FINLAYSON, R. (2005) · Regional Anesthesia & Pain Medicine · doi:10.1016/j.rapm.2005.04.007 · Cited by 18 · see citing works
Greenlaw, C. W., & NULL, L. H. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90683-3 · Cited by 18 · see citing works
Bunker, N., & Higgins, D. M. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000202202.85087.37 · Cited by 17 · see citing works
Cutaneous necrosis following peripheral intravenous vasopressin therapy.
Wormser, G. P., Kornblee, L. V., & Gottfried, E. B. (1982) · PubMed · Cited by 15 · see citing works
Extravasation and tissue necrosis secondary to central line infusions
Davies, A. G., Russell, W. C., & Thompson, J. P. (2003) · Anaesthesia · doi:10.1046/j.1365-2044.2003.03295_26.x · Cited by 14 · see citing works
Deterling, R. A., & Apgar, V. (1951) · Annals of Surgery · doi:10.1097/00000658-195101000-00003 · Cited by 14 · see citing works
Ischemia of the hand secondary to levarterenol bitartrate extravasation. Methods of management
Weeks, P. M. (1966) · JAMA · doi:10.1001/jama.196.3.288 · Cited by 14 · see citing works
Tran, D. Q. H., & Finlayson, R. J. (2005) · Regional Anesthesia & Pain Medicine · doi:10.1097/00115550-200507000-00014 · Cited by 14 · see citing works
TREATMENT OF LOCAL ISCHEMIA DUE TO LEVARTERENOL (LEVOPHED) LEAKAGE WITH PIPEROXAN
Pelner, L. (1957) · JAMA · doi:10.1001/jama.1957.02980230014004 · Cited by 13 · see citing works
Treatment of Shock and Prevention of Ischemic Necrosis with Levarterenol-Phentolamine Mixtures
Zucker, G., Eisinger, R. P., Floch, M. H., et al. (1960) · Circulation · doi:10.1161/01.cir.22.5.935 · Cited by 12 · see citing works
Be, C. (1989) · PubMed · Cited by 12 · see citing works
Spontaneous rupture of the esophagus
Irvin, C. W., & Bunch, G. H. (1954) · The American Journal of Medicine · doi:10.1016/0002-9343(54)90132-1 · Cited by 10 · see citing works
Skin necrosis following intravenous use of norepinephrine; case reports.
Kepes, E. R., Haimovici, H., & Simon, B. E. (1954) · PubMed · Cited by 10 · see citing works
Necrosis Following Intravenous Use of Neo-Synephrine
Peirce, E. C., & Polley, V. B. (1954) · New England Journal of Medicine · doi:10.1056/nejm195401212500305 · Cited by 9 · see citing works
Extravasation injury by norepinephrine: a case report and description of treatment options
van der Wal, G. (2013) · Cited by 9 · see citing works
Tissue necrosis associated with intravenous nor-epinephrine administration.
Alvarez, R. R. D., Nyhus, L. M., MERENDINO, K. A., et al. (1957) · PubMed · Cited by 8 · see citing works
Advantages and disadvantages of prolonged use of nor-epinephrine.
Bergmann, H. (1953) · PubMed · Cited by 8 · see citing works
Necrosis Following Administration of Levarterenol During Shock
WALL, C. A. (1956) · Archives of Surgery · doi:10.1001/archsurg.1956.01270200148026 · Cited by 7 · see citing works
RECOVERY OF PATIENT IN PROLONGED SHOCK AFTER ARTERENOL THERAPY
Hall, B. (1955) · JAMA · doi:10.1001/jama.1955.02950250027007 · Cited by 7 · see citing works
CRAWFORD, E. S., & Bw, H. (1953) · PubMed · Cited by 7 · see citing works
TREATMENT OF TISSUE NECROSIS FOLLOWING INTRAVENOUS USE OF NOREPINEPHRINE
HARDY, S. B., & Hamilton, J. M. (1957) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-195711000-00003 · Cited by 6 · see citing works
Local Skin Necrosis after Intravenous Infusion of Norepinephrine, and the Concept of Endotoxinaemia
Fritz, H., Hagstam, K., & Lindqvist, B. (1965) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1965.tb04285.x · Cited by 6 · see citing works
Skin necrosis with the intravenous use of norepinephrine.
Hardie, G. H., & HUNTER, D. C. (1955) · PubMed · Cited by 5 · see citing works
Ramadan, H., Aksu, N. M., Akkaş, M., et al. (2013) · PubMed · Cited by 5 · see citing works
Toxidermie bulleuse après traitement par terlipressine intraveineuse
Tomassini, E., Guiot, P., Poussel, J. F., et al. (2000) · Réanimation Urgences · doi:10.1016/s1164-6756(00)80014-6 · Cited by 5 · see citing works
[Necrosis of the skin and fingers in the course of noradrenaline administration].
Dutkowski, R. (1966) · PubMed · Cited by 5 · see citing works
[Skin necrosis following administration of vasopressin].
Rh, H., & Leguit, P. (1987) · PubMed · Cited by 4 · see citing works
Histamine iontophoresis to prevent tissue necrosis following levarterenol extravasation.
Selke, O. O. (1956) · PubMed · Cited by 4 · see citing works
[Clinical and animal experiment studies on skin necroses after infusion of vasopressor solutions].
Rittmeyer, P. (1963) · PubMed · Cited by 4 · see citing works
[Skin necrosis due to dopamine infusion].
Pillgram-Larsen, J., & Nicolaisen, B. (1982) · PubMed · Cited by 4 · see citing works
Skin Necrosis in Nor‐adrenaline Therapy
Heard, G. (1957) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1957.tb02278.x · Cited by 4 · see citing works
Epidermal Necrosis due to Nor-Adrenaline.
Mitchinson, M. J., & Gresham, G. A. (1964) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1964.tb15495.x · Cited by 3 · see citing works
Intravascular Guanethidine in the Treatment of Extravasated Vasopressin
Crocker, M. C. (1981) · New England Journal of Medicine · doi:10.1056/nejm198106043042321 · Cited by 3 · see citing works
Cutaneous necrosis due to norepinephrine: analysis of reported cases and surgical treatment.
CLOSE, A. S., & Wh, F. (1958) · PubMed · Cited by 3 · see citing works
Nécrose tissulaire après injection paraveineuse accidentelle de dopamine
Steib, A., Jeanpierre, C., Mole, J. P., et al. (1984) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(84)80133-1 · Cited by 2 · see citing works
PREVENTION OF NOREPINEPHRINE (LEVOPHED) SLOUGHS
BRYANT, M. F., BERBEN, J. Y., & Howard, J. M. (1958) · Survey of Anesthesiology · doi:10.1097/00132586-195810000-00006 · Cited by 2 · see citing works
[Cutaneous necrosis caused by vasopressin].
González, G. O., Boix, M. M., Frutos, M. D. M., et al. (1985) · PubMed · Cited by 2 · see citing works
[Local complications of noradrenalin intravenous drip].
Lindgren, S. (1954) · PubMed · Cited by 2 · see citing works
GANGRENE FOLLOWING INFUSION OF NOREPINEPHRINE. REPORT OF A CASE.
Rs, G. (1964) · PubMed · Cited by 2 · see citing works
[Skin necrosis after noradrenalin injection].
Hj, P. (1956) · PubMed · Cited by 2 · see citing works
Prevention of norepinephrine (levophed) sloughs.
BRYANT, M. F., Jy, B., & Jm, H. (1957) · PubMed · Cited by 2 · see citing works
LOCAL TISSUE NECROSIS AND CUTANEOUS GANGRENE FOLLOWING INTRAVENOUS INFUSION OF NORADRENALINE.
Mp, M., & Kishore, B. (1963) · PubMed · Cited by 2 · see citing works
MASSIVE GANGRENE OF THE LOWER LIMB FOLLOWING USE OF CONTINUOUS NORADRENALINE INTRAVENOUS INFUSION
Jaconelli, J. (1965) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1965.tb71404.x · Cited by 2 · see citing works
Vilain, R. C., & Cukier, J. (1961) · PubMed · Cited by 2 · see citing works
[Cutaneous necrosis occurring after perfusion of 2 vaso-pressors].
Dugois, P., Imbert, R., Amblard, P., et al. (1970) · PubMed · Cited by 2 · see citing works
Rupčić, N. (2014) · Cited by 2 · see citing works
[ETIOPATHOGENESIS AND TREATMENT OF NECROTIC ESCHARS DUE TO NOREPINEPHRINE USED INTRAVENOUSLY].
LIVY, A. M. (1964) · PubMed · Cited by 1 · see citing works
Infusion of noradrenaline through the proximal line of a migrated central venous catheter
Freer, M., & Noble, S. I. R. (2012) · Scottish Medical Journal · doi:10.1258/smj.2012.012027 · Cited by 1 · see citing works
Yoon, S., Kim, T., Lee, S., et al. (2003) · Linchuang pifuke zazhi · Cited by 1 · see citing works
[REGIONAL NECROSIS FOLLOWING NORADRENALINE ADMINISTRATION].
Vieira, Z. G. (1996) · PubMed · Cited by 1 · see citing works
[Skin necrosis after frip infusion of norepinephrine].
Sienkiewicz, F. (1966) · PubMed · Cited by 1 · see citing works
[Cutaneous necrosis caused by noradrenaline infusion].
Tappura, M. (1962) · PubMed · Cited by 1 · see citing works
[Cutaneous necroses after use of noradrenaline perfusions. Reflexions on 5 personal cases].
Schnoebelen, R., Traumann, P., & FORSTER, E. (1998) · PubMed · Cited by 1 · see citing works
[Cutaneous necrosis caused by noradenaline].
Ar, E. C., Soler, F., & Benítez de Aldama, E. (1965) · PubMed · Cited by 1 · see citing works
[Superficial gangrene after infusion of noradrenalin substances in patients in hypothermia].
Cioffi, F., & Bisiani, M. (1965) · PubMed · Cited by 1 · see citing works
[SKIN NECROSIS OF THE EXTREMITIES FOLLOWING THE INTRAVENOUS ADMINISTRATION OF NORADRENALIN].
Ciesielski, L. (1963) · PubMed · Cited by 1 · see citing works
[Noradrenalin therapy and local complications].
Fekete, G. (1957) · PubMed · Cited by 1 · see citing works
[Extensive cutaneous necrosis following prolonged intravenous injection of L. noradrenaline].
Mercier, R., Planchon, E., & Mercier, M. (1998) · PubMed · Cited by 1 · see citing works
Delannoy, E., & DOUMER, E. (2003) · PubMed · Cited by 1 · see citing works
[Skin necrosis following noradrenalin infusion].
Nc, N. (1958) · PubMed · Cited by 1 · see citing works
[Skin necrosis after prolonged intravenous infusion of noradrenalin].
Jungmann, V. (1961) · PubMed · Cited by 1 · see citing works
Jg, K., Sh, C., & Yoon, T.-M. (1997) · Linchuang pifuke zazhi · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935 · see citing works
Safety of peripheral administration of vasopressor medications: A systematic review
Tian, D. H., Smyth, C., Keijzers, G., Macdonald, S. P., Peake, S., Udy, A., & Delaney, A. (2020) · Emergency Medicine Australasia · doi:10.1111/1742-6723.13406 · Cited by 160 · see citing works
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082 · see citing works
Delaney, A., Finnis, M., Bellomo, R., Udy, A., Jones, D., Keijzers, G., MacDonald, S., & Peake, S. (2020) · Emergency Medicine Australasia · doi:10.1111/1742-6723.13394 · Cited by 71 · see citing works
- Authors
- Loubani, O. M., & Green, R. S.
- Affiliations
- Dalhousie University (CA)
- Corresponding author
- Loubani, Osama M.
- Venue
- Journal of Critical Care
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 30
- Issue
- 3
- Pages
- 653.e9-653.e17
- ISSN
- 0883-9441 (ISSN-L)
- OpenAlex
- W2074225649
- Cited by
- 235
- References
- 95
- Citations by year
- 2026: 14 · 2025: 21 · 2024: 35 · 2023: 26 · 2022: 27 · 2021: 29 · 2020: 24 · 2019: 17 · 2018: 13 · 2017: 16 · 2016: 9 · 2015: 3 · 2013: 1
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Critical Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Dalhousie University
- Topics
- Health Sciences › Health Professions › Emergency Medical Services › Central Venous Catheters and Hemodialysis
- Physical Sciences › Engineering › Biomedical Engineering › Intravenous Infusion Technology and Safety
- Health Sciences › Medicine › Dermatology › Chemotherapy-related skin toxicity
- Keywords
- vasopressors, extravasation, local tissue injury, peripheral intravenous catheters, central venous catheters
- MeSH terms
- Catheterization, Central Venous, Catheterization, Peripheral, Extravasation of Diagnostic and Therapeutic Materials, Humans, Infusions, Intravenous, Necrosis, Vasoconstrictor Agents, Critical Illness, Soft Tissue Injuries, Vascular Access Devices, Central Venous Catheters
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review